Financhill
Back

NovoCure Stock Predictions

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 48.6% based on the past 9 years of stock performance.
  • NovoCure has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $21.71. The Score for NVCR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 48.6% based on the past 9 years of stock performance.

NovoCure Stock Rating

Sell
30
NovoCure (NVCR) is a Sell

Is NovoCure overpriced?

  • NovoCure has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
34.13
52-Week Low:
11.70

Prediction Charts

Market Cap:
2.3B
Price in USD:
21.71
Volume:
548.5K
Beta:
1.03

Technical Analysis

SMA50:
27.63
SMA100:
22.12
SMA200:
20.48
52-Wk Change:
45.51%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price is 21.71 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-27 26.00 25.38 26.36 25.15
Jan-28 25.53 25.57 25.94 24.92
Jan-29 25.51 25.52 25.75 25.10
Jan-30 25.97 25.51 26.47 25.49
Jan-31 25.69 24.52 25.79 24.33
Feb-3 23.95 23.75 24.13 23.45
Feb-4 23.74 23.67 23.87 23.08
Feb-5 23.67 24.18 24.73 23.51
Feb-6 24.19 22.93 24.19 22.88
Feb-7 22.81 22.25 23.18 22.03
Feb-10 22.31 21.65 22.31 21.52
Feb-11 21.24 21.21 21.66 21.02
Feb-12 20.85 21.37 21.40 20.72
Feb-13 21.60 21.71 21.82 21.36

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.03 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.